The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...